Actinium Pharmaceuticals, Inc.

NYSE American: ATNM · Healthcare

Positivity Index

#4,890 / 6,774

Global

#2,560 / 4,000

United States

Positivity Score

18,801

Rank→

PosiRed: 2 active red flags (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 14 Aug 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 29 May 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Actinium Pharmaceuticals, Inc. — Overview & Financial Snapshot

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) is a Healthcare company, ranked #4,890 of 6,774 companies globally and #2,560 of 4,000 in United States on PositoAI, with a Positivity Score of 18,801. Its market capitalisation is ₹474.85 Cr ($50.31M), P/E ratio is 4.4 and P/B ratio is 1.66. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Actinium Pharmaceuticals, Inc. do?

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase…

What is Actinium Pharmaceuticals, Inc.'s P/E and P/B ratio?

Actinium Pharmaceuticals, Inc. has a P/E ratio of 4.4 and a P/B ratio of 1.66.

What is Actinium Pharmaceuticals, Inc.'s debt-to-equity ratio?

Actinium Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.04.

How much does Actinium Pharmaceuticals, Inc. owe compared with what it owns?

Actinium Pharmaceuticals, Inc. owes $0.25 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Actinium Pharmaceuticals, Inc.'s Positivity rank?

Actinium Pharmaceuticals, Inc. is ranked #4,890 of 6,774 companies globally and #2,560 of 4,000 in United States on PositoAI, with a Positivity Score of 18,801.

Does Actinium Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Actinium Pharmaceuticals, Inc. has 2 active red flags (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 14 Aug 2026); Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 29 May 2026). It has no yellow flags.

Where can I read the latest news about Actinium Pharmaceuticals, Inc.?

Recent headlines about Actinium Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Actinium Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Actinium Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.